22nd Century Group
22nd Century Group is a biotechnology company based in Williamsville, New York, specializing in plant biotechnology to create products that reduce the harm associated with tobacco use and promote smoking cessation. Founded in 1998, the company focuses on altering nicotine levels in tobacco through genetic engineering and plant breeding. It offers very low nicotine content (VLNC) tobacco cigarettes marketed under the Moonlight and Moonlight Menthol brands, alongside SPECTRUM research cigarettes intended for independent clinical studies. The firm is also involved in contract manufacturing for third-party branded tobacco products. Additionally, 22nd Century Group has a strategic partnership with Keygene N.V. to develop hemp and cannabis plants for various applications, including medical and agricultural uses. The company's innovative approach aims to provide consumers with healthier alternatives in tobacco products.
GVB Biopharma
Acquisition in 2022
GVB Biopharma, founded in 2016 and headquartered in Las Vegas, Nevada, focuses on hemp processing and the manufacturing of cannabinoid-based consumer products. The company is involved in the organic cultivation, research, development, and marketing of hemp-based wellness solutions for a global audience. GVB Biopharma emphasizes the life-enhancing qualities of CBD and other hemp-derived products, dedicating significant resources to research across all aspects of hemp cultivation and production. In addition, the company operates cannabis seed testing facilities that conduct thorough testing to ensure the safety and purity of its CBD products, thereby assisting clients in the creation of diverse hemp offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.